文献速递临床试验与 GCP基础与转化研究

i-PRF在成熟恒牙牙髓坏死再生牙髓治疗中的疗效:多中心随机对照试验方案

Efficacy of i-PRF in regenerative endodontics therapy for mature permanent teeth with pulp necrosis: study protocol for a multicentre randomised controlled trial.
PubMed 文献 · Trials · 2021-07-06

本研究为随机双盲对照多中心临床试验方案,计划从三个中心招募346例成熟恒牙牙髓坏死患者,按1:1随机分配接受血凝块或i-PRF作为支架的再生牙髓治疗。主要结局为24个月后RET成功率,次要结局为牙髓活力变化,并记录不良反应。

要点

  • 评估RET在成熟恒牙牙髓坏死中的临床可行性。
  • 比较i-PRF与血凝块作为支架的RET疗效。
  • 24个月随访成功率及牙髓活力变化为主要观察指标。

核心结论

  • 该试验将评估RET在成熟恒牙牙髓坏死中的临床可行性,并提供i-PRF作为支架的疗效、获益与安全性信息。

研究设计与样本

  • 随机、双盲、对照、多中心临床试验方案,计划从三个中心招募346例患者,按1:1随机分配接受血凝块或i-PRF支架的RET。
  • 纵向追踪主观症状、临床检查和影像学检查24个月。

主要发现

  • 原文为研究方案,未报告试验结果。

关键数值与推荐

  • 主要结局为24个月后RET成功率。
  • 次要结局为通过冷热诊和电活力测试测量的牙髓活力变化。
  • 记录变色、再感染和牙根吸收等不良事件发生率用于安全性评价。

临床怎么用

  • 若试验证实i-PRF有效,可能扩展RET适应证至成熟恒牙牙髓坏死,并作为新型生物支架提高临床可行性。

局限性

  • 原文为研究方案,尚无结果数据;结论需待试验完成后确定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Dental pulp necrosis, a common health problem, is traditionally treated with root canal therapy; however, it fails in restoring the vitality of damaged pulp. Most studies regarding regenerative endodontic therapy (RET) are limited to the treatment of immature necrotic teeth. Given that injectable platelet-rich fibrin (i-PRF) has shown great potential in regenerative medicine as a novel platelet concentration, this study is designed to explore whether i-PRF can serve as a biological scaffold, extending the indications for RET and improving the clinical feasibility of RET in mature permanent teeth with pulp necrosis. METHODS: This is a randomised, double-blind, controlled, multicentre clinical trial designed to evaluate the clinical feasibility of RET for mature permanent teeth with pulp necrosis and to compare the efficacy of i-PRF and blood clots as scaffolds in RET. A total of 346 patients will be recruited from three centres and randomised at an allocation ratio of 1:1 to receive RET with either a blood clot or i-PRF. The changes in subjective symptoms, clinical examinations, and imaging examinations will be tracked longitudinally for a period of 24 months. The primary outcome is the success rate of RET after 24 months. The secondary outcome is the change in pulp vitality measured via thermal and electric pulp tests. In addition, the incidence of adverse events such as discolouration, reinfection, and root resorption will be recorded for a safety evaluation. DISCUSSION: This study will evaluate the clinical feasibility of RET in mature permanent teeth with pulp necrosis, providing information regarding the efficacy, benefits, and safety of RET with i-PRF. These results may contribute to changes in the treatment of pulp necrosis in mature permanent teeth and reveal the potential of i-PRF as a novel biological scaffold for RET. TRIAL REGISTRATION: ClinicalTrials.gov NCT04313010 . Registered on 19 March 2020.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Liang Y, Ma R, Chen L, et al. Efficacy of i-PRF in regenerative endodontics therapy for mature permanent teeth with pulp necrosis: study protocol for a multicentre randomised controlled trial. Trials. 2021. PMID: 34229752. doi:10.1186/s13063-021-05401-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。